In the past 10 years, a deeper understanding of the immune landscape of cancers, including
immune evasion processes, has allowed the development of a new class of agents. The …

Thymic carcinomas are rare malignancies that in general arise in the prevascular (anterior)
mediastinum. These tumors are usually invasive, often present at advanced stages, and …

Background Thymic carcinoma is a rare malignant disease and standard treatment for
advanced or metastatic thymic carcinoma previously treated with platinum-based …

The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …

Good and effective treatment in radiotherapy requires careful consideration of the complex
variables involved as well as critical assessment of the techniques. This new edition of an …

Introduction Thymic carcinoma (TC) is a rare cancer with a poor prognosis and limited
treatment options, especially after relapse. Methods In this open-label, two-stage …

Simple Summary Surgery is the main treatment for thymic tumors, and multidisciplinary
treatment would benefit patients a lot. Despite numerous technological advances in the …

Combination of photodynamic therapy and chemotherapy has been emerging as a new
strategy for cancer treatment. Conventional photosensitizer tends to aggregate in aqueous …

Background Thymic malignancies represent a heterogeneous group of rare thoracic
cancers, which are classified according to the World Health Organization histopathologic …

Abstract Introduction Thymic epithelial tumors (TETs) are rare malignancies that may be
aggressive and difficult to treat. In the advanced setting, systemic treatments may be …